Cargando…

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy

Alzheimer's disease (AD) is a main cause of dementia, accounting for up to 75% of all dementia cases. Pathophysiological processes described for AD progression involve neurons and synapses degeneration, mainly characterized by cholinergic impairment. This feature makes acetylcholinesterase inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Santos, Thaiane Coelho, Gomes, Thaís Mota, Pinto, Bruno Araújo Serra, Camara, Adriana Leandro, Paes, Antonio Marcus de Andrade
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201143/ https://www.ncbi.nlm.nih.gov/pubmed/30405413 http://dx.doi.org/10.3389/fphar.2018.01192

Ejemplares similares

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection
por: Ayatollahi, Seyed Abdulmajid, et al.
Publicado: (2021)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
por: Sun, Shouyuan, et al.
Publicado: (2022)

Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives
por: Tan, Hui-Li, et al.
Publicado: (2016)

Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
por: Mühlhaus, Jessica, et al.
Publicado: (2017)

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2022)

Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2023)

Hupresin Retains Binding Capacity for Butyrylcholinesterase and Acetylcholinesterase after Sanitation with Sodium Hydroxide
por: Onder, Seda, et al.
Publicado: (2017)

Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase
por: Girgin, Münteha, et al.
Publicado: (2023)

Strong and Long-Lasting Antinociceptive and Anti-inflammatory Conjugate of Naturally Occurring Oleanolic Acid and Aspirin
por: Bednarczyk-Cwynar, Barbara, et al.
Publicado: (2016)

Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens
por: He, Liangliang, et al.
Publicado: (2022)

Therapeutic Effects of Natural Drugs on Alzheimer’s Disease
por: Ma, Yuan, et al.
Publicado: (2019)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases
por: Chagas, Vinicyus Teles, et al.
Publicado: (2015)

Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors
por: Lockridge, Oksana, et al.
Publicado: (2016)

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
por: Paroni, Giulia, et al.
Publicado: (2014)

Acetylcholinesterase-Inhibition and Antibacterial Activity of Mondia whitei Adventitious Roots and Ex vitro-Grown Somatic Embryogenic-Biomass
por: Baskaran, Ponnusamy, et al.
Publicado: (2016)

Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
por: Petrov, Konstantin A., et al.
Publicado: (2018)

Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease
por: Shal, Bushra, et al.
Publicado: (2018)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
por: Shi, Zhikun, et al.
Publicado: (2022)

Experience-Related Changes in Place Cell Responses to New Sensory Configuration That Does Not Occur in the Natural Environment in the Rat Hippocampus
por: Zou, Dan, et al.
Publicado: (2017)

Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022)

Hyperactivity of medial prefrontal cortex pyramidal neurons occurs in a mouse model of early-stage Alzheimer’s disease without β-amyloid accumulation
por: Choudhury, Nasreen, et al.
Publicado: (2023)

Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatum (Lamarck) Leaf Extract in Experimental Colitis Models in Rodents
por: Andrade, Anderson Wilbur Lopes, et al.
Publicado: (2020)

N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
por: Toiber, Debra, et al.
Publicado: (2008)

Circumdatin D Exerts Neuroprotective Effects by Attenuating LPS-Induced Pro-Inflammatory Responses and Downregulating Acetylcholinesterase Activity In Vitro and In Vivo
por: Zhang, Chanjuan, et al.
Publicado: (2020)

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver–Gut Axis
por: Liu, Linlin, et al.
Publicado: (2020)

Trilobatin, a Naturally Occurring Food Additive, Ameliorates Exhaustive Exercise-Induced Fatigue in Mice: Involvement of Nrf2/ARE/Ferroptosis Signaling Pathway
por: Xiao, Ran, et al.
Publicado: (2022)

Analogous β-Carboline Alkaloids Harmaline and Harmine Ameliorate Scopolamine-Induced Cognition Dysfunction by Attenuating Acetylcholinesterase Activity, Oxidative Stress, and Inflammation in Mice
por: Li, Shu-Ping, et al.
Publicado: (2018)

Editorial: Treatment of Alzheimer’s disease-discovery of natural products based on neurite outgrowth and neuroprotection
por: Yang, Zhiyou, et al.
Publicado: (2022)

The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer’s disease: A review
por: Ahmad, Nazir, et al.
Publicado: (2022)

Gene Therapy Using Plasmid DNA Encoding VEGF164 and FGF2 Genes: A Novel Treatment of Naturally Occurring Tendinitis and Desmitis in Horses
por: Kovac, Milomir, et al.
Publicado: (2018)

The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer’s Disease Pathophysiology
por: Belo, Rita F., et al.
Publicado: (2020)

NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer’s Disease
por: Bellozi, Paula Maria Quaglio, et al.
Publicado: (2019)

Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors
por: Ferris, Steven H, et al.
Publicado: (2013)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
por: Vecchio, Immacolata, et al.
Publicado: (2021)

The Serotonin Receptor 6 Antagonist Idalopirdine and Acetylcholinesterase Inhibitor Donepezil Have Synergistic Effects on Brain Activity—A Functional MRI Study in the Awake Rat
por: Ferris, Craig F., et al.
Publicado: (2017)

Natural Peptides in Drug Discovery Targeting Acetylcholinesterase
por: Prasasty, Vivitri, et al.
Publicado: (2018)

Biocomputational Screening of Natural Compounds against Acetylcholinesterase
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021)

Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer’s Disease
por: Dong, Xiaoyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dkqumq2s5879kdclbulkah6v4j